# Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

> **NCT05118672** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 567 (actual)

## Conditions studied

- Cold
- Flu Symptom

## Interventions

- **DRUG:** Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05118672
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-26
- **Primary completion:** 2025-08-26
- **Final completion:** 2025-08-26
- **Target enrollment:** 567 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05118672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05118672, "Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05118672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*